Tools

LEADER 03516nas 2200649 i 4500

001 on1445696175;

003 OCoLC;

005 20241021155040.0;

006 m o d f ;

007 cr |||||||||||;

008 240710c20209999dcuar o f| 0eng c;

010 a| 2024233173;

035 a| (Sirsi) o1445696175;

042 a| pcc;

043 a| n-us---;

049 a| ERE#;

074 a| 0512-A-01 (online);

086 0 a| HE 22.2:D 84/9/;

110 2 a| Centers for Medicare & Medicaid Services (U.S.),0| https://id.loc.gov/authorities/names/no2001093385,e| author.=| ^A503728;

245 10 a| Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities Act: section 1004 Medicaid drug review and utilization, federal fiscal year ... report to Congress.;

246 1 i| Running title:a| FFY ... annual report to Congress: Medicaid drug review and utilization requirements under section 1004 of the SUPPORT Act;

246 1 i| Title from agency website:a| Report to Congress - Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities Act: section 1004 Medicaid drug review and utilization;

264 1 a| Washington, D.C. :b| Health and Human Services Department, Centers for Medicare and Medicaid Services,c| 2022-;

300 a| 1 online resource (volumes) :b| illustrations;

310 a| Annual;

336 a| textb| txt2| rdacontent;

337 a| computerb| c2| rdamedia;

338 a| online resourceb| cr2| rdacarrier;

362 1 a| Began with: FFY 2020.;

500 a| In scope of the U.S. Government Publishing Office Cataloging and Indexing Program (C&I) and Federal Depository Library Program (FDLP).;

500 a| United States federal government branch: Executive branch.;

500 a| Access ID (GovInfo): CMR-HE22-00187857.;

500 a| Legal authority: section 1902(oo)(2) of the Social Security Act.;

500 a| United States Congress receiving chamber(s): United States House of Representatives and Senate.;

500 a| GPO Cataloging Record Distribution Program (CRDP).;

588 0 a| FFY 2020; title from PDF cover (Medicaid.gov website, viewed July 08, 2024).;

588 1 a| FFY 2021 (GovInfo, viewed July 08, 2024).;

610 10 a| United States.t| Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities Act.0| https://id.loc.gov/authorities/names/no2019145037=| ^A1454259;

650 0 a| Drug utilizationz| United States.=| ^A991416;

650 0 a| Medicaid beneficiariesz| United States.=| ^A628217;

650 0 a| Opioid abusez| United States.=| ^A1017318;

650 0 a| Antipsychotic drugs.0| https://id.loc.gov/authorities/subjects/sh89002390=| ^A828690;

650 0 a| Medicaid fraudx| Prevention.=| ^A368699;

650 7 a| Medicare.2| lst;

650 7 a| Drug, alcohol, tobacco use.2| lst;

650 7 a| Social security and elderly assistance.2| lst;

650 7 a| Medicaid.2| lst;

655 7 a| Annual reports.2| lcgft0| https://id.loc.gov/authorities/genreForms/gf2014026046;

856 40 3| Available from GovInfou| https://purl.fdlp.gov/GPO/gpo2308877| 0;

856 40 3| Available from Medicare.govu| https://purl.fdlp.gov/GPO/gpo2308887| 0;

922 a| CONSERNEWb| 20240710;

922 a| CMRb| 20240710;

949 a| Click on web addressw| asish| joyner94;

596 a| 1;

998 a| 6463257;

999 a| CLICK ON WEB ADDRESSw| ASISc| 1i| 6463257-1001l| JNETm| JOYNERr| Ys| Yt| JNE1DOu| 8/12/2024x| EDOCUMENTz| JERESOURCE;

Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities Act: section 1004 Medicaid drug review and utilization, federal fiscal year ... report to Congress.

Author/creator	Centers for Medicare & Medicaid Services (U.S.)
Format	Electronic
Publication	Washington, D.C. : Health and Human Services Department, Centers for Medicare and Medicaid Services, 2022-
Description	1 online resource (volumes) : illustrations
Supplemental Content	Available from GovInfo
Supplemental Content	Available from Medicare.gov
Subjects	United States. Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities Act. Drug utilization--United States. Medicaid beneficiaries--United States. Opioid abuse--United States. Antipsychotic drugs. Medicaid fraud--Prevention.

Variant title	Running title: FFY ... annual report to Congress: Medicaid drug review and utilization requirements under section 1004 of the SUPPORT Act
Variant title	Title from agency website: Report to Congress - Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities Act: section 1004 Medicaid drug review and utilization
Frequency	Annual
General note	In scope of the U.S. Government Publishing Office Cataloging and Indexing Program (C&I) and Federal Depository Library Program (FDLP).
General note	United States federal government branch: Executive branch.
General note	Access ID (GovInfo): CMR-HE22-00187857.
General note	Legal authority: section 1902(oo)(2) of the Social Security Act.
General note	United States Congress receiving chamber(s): United States House of Representatives and Senate.
General note	GPO Cataloging Record Distribution Program (CRDP).
Source of description	FFY 2020; title from PDF cover (Medicaid.gov website, viewed July 08, 2024).
Source of description	FFY 2021 (GovInfo, viewed July 08, 2024).
Genre/form	Annual reports.
LCCN	2024233173
GPO item number	0512-A-01 (online)
Govt. docs number	HE 22.2:D 84/9/

Availability

Library	Location	Call Number	Status	Item Actions
	Electronic Resources	Online Content Available from GovInfo Available from Medicare.gov	✔ Available

Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities Act: section 1004 Medicaid drug review and utilization, federal fiscal year ... report to Congress.

Click here for more information about this title

Availability